RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $172,704 | -59.6% | 986,878 | 0.0% | 0.06% | -58.6% |
Q3 2022 | $428,000 | -49.0% | 986,878 | 0.0% | 0.14% | -49.3% |
Q2 2022 | $840,000 | -84.6% | 986,878 | 0.0% | 0.28% | -75.1% |
Q1 2022 | $5,438,000 | -43.1% | 986,878 | 0.0% | 1.11% | -9.1% |
Q4 2021 | $9,553,000 | -45.9% | 986,878 | 0.0% | 1.22% | -26.3% |
Q3 2021 | $17,645,000 | -26.8% | 986,878 | 0.0% | 1.66% | -28.1% |
Q2 2021 | $24,090,000 | -7.9% | 986,878 | 0.0% | 2.30% | -34.3% |
Q1 2021 | $26,152,000 | +249.2% | 986,878 | 0.0% | 3.51% | +19.8% |
Q4 2020 | $7,490,000 | +51.5% | 986,878 | 0.0% | 2.93% | +59.9% |
Q3 2020 | $4,944,000 | -16.2% | 986,878 | 0.0% | 1.83% | -28.1% |
Q2 2020 | $5,902,000 | +34.4% | 986,878 | 0.0% | 2.54% | +20.0% |
Q1 2020 | $4,392,000 | -53.2% | 986,878 | 0.0% | 2.12% | -45.1% |
Q4 2019 | $9,375,000 | +21.0% | 986,878 | 0.0% | 3.86% | +19.9% |
Q3 2019 | $7,747,000 | -75.0% | 986,878 | -50.0% | 3.22% | -44.5% |
Q2 2019 | $31,048,000 | +73.8% | 1,973,756 | +100.0% | 5.81% | -8.1% |
Q1 2019 | $17,862,000 | +12.6% | 986,878 | 0.0% | 6.32% | -15.9% |
Q4 2018 | $15,869,000 | -33.0% | 986,878 | 0.0% | 7.52% | -64.9% |
Q3 2018 | $23,685,000 | – | 986,878 | – | 21.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |